Daily Archives: June 26, 2017

Information for Authors and Readers

Gastroenterology is the premiere journal in the field of gastrointestinal disease and is led by an internationally renowned board of editors. As the official journal of the AGA Institute, Gastroenterology delivers up-to-date and authoritative coverag… Continue reading

Posted in News | Comments Off on Information for Authors and Readers

Elsewhere in The AGA Journals

Posted in News | Comments Off on Elsewhere in The AGA Journals

Table of Contents

Posted in News | Comments Off on Table of Contents

Editorial Board

Posted in News | Comments Off on Editorial Board

Reply

We appreciate the comments by Hayakawa and Wang on our original study.1 They raise important issues concerning the location of stem cells as well as the origin of metaplasia in the stomach. Continue reading

Posted in News | Comments Off on Reply

Reply

We thank Dr Khan and Dr Assaraf for their responses to our publication.1 Continue reading

Posted in News | Comments Off on Reply

Cover 1

Posted in News | Comments Off on Cover 1

Hyperplasia of Interstitial Cells of Cajal Leads to Rapid Gastric Emptying in Diabetes

Coordinated contractions of the stomach are integrated motor responses classically described as consisting of “neurogenic” and “myogenic” components. In the last 2 decades, dissection of the myogenic elements using genetic, molecular, morpholog… Continue reading

Posted in News | Comments Off on Hyperplasia of Interstitial Cells of Cajal Leads to Rapid Gastric Emptying in Diabetes

A Penetrating Look at Eosinophilic Esophagitis Pathogenesis: Direct Antigen Exposure in the Esophagus?

Marietta EV, Geno DM, Smyrk TC, et al. Presence of intraepithelial food antigen in patients with active eosinophilic oesophagitis. Aliment Pharmacol Ther 2017;45:427–433. Continue reading

Posted in News | Comments Off on A Penetrating Look at Eosinophilic Esophagitis Pathogenesis: Direct Antigen Exposure in the Esophagus?

Filgotinib in Crohn Disease: JAK Is Back

Vermeire S, Schreiber S, Petryka R, et al. Clinical remission in patients with moderate-to-severe Crohn’s disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial. Lancet 2017;389:… Continue reading

Posted in News | Comments Off on Filgotinib in Crohn Disease: JAK Is Back